国家: 澳大利亚
语言: 英文
来源: Department of Health (Therapeutic Goods Administration)
chlorpromazine hydrochloride, Quantity: 10 mg
Sanofi-Aventis Australia Pty Ltd
Tablet, film coated
Excipient Ingredients: lactose monohydrate; maize starch; colloidal anhydrous silica; hypromellose; macrogol 200; magnesium stearate; titanium dioxide; purified water; industrial methylated spirit
Oral
100 tablets
(S4) Prescription Only Medicine
1. Treatment of acute functional psychosis (eg schizophrenia, mania or psychotic depression). 2. Long-term treatment of schizophrenia. 3. Short-term treatment of agitation and severe depression. 4. Severe behavioural disturbances, as can be found in some children with mental retardation or autism, including the treatment of self-injurious and aggressive behaviour or overactivity. Use of chlorpromazine should be in conjunction with an appropriate non-pharmacological management program and long-term use should only be carried out under the supervision of a physician experienced in the management of psychotic disorders in children. 5. In the management of terminal illness to enhance the effect of analgesics and to control nausea and vomiting. 6. Control of intractable hiccough.
Visual Identification: White to off white circular biconvex, film- coated tablets one face impressed LG10 with the reverse side plain.; Container Type: Blister Pack; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius
Licence status A
1995-04-26
LARGACTIL ® L a r g a c t i l ® CONSUMER MEDICINE INFORMATION (CMI) SUMMARY The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. 1. WHY AM I USING LARGACTIL? Largactil contains the active ingredient chlorpromazine hydrochloride, one of a group of medicines called phenothiazines. Largactil is used to treat several conditions and may be used either for a short time or for a long time. Ask your doctor if you have any questions about why Largactil has been prescribed for you. Largactil is available only with a doctor's prescription. For more information, see Section 1. Why am I using Largactil? in the full CMI. 2. WHAT SHOULD I KNOW BEFORE I USE LARGACTIL? Do not use if you have ever had an allergic reaction to Largactil or any of the ingredients listed at the end of the CMI. TALK TO YOUR DOCTOR IF YOU HAVE ANY OTHER MEDICAL CONDITIONS, TAKE ANY OTHER MEDICINES, OR ARE PREGNANT OR PLAN TO BECOME PREGNANT OR ARE BREASTFEEDING. For more information, see Section 2. What should I know before I use Largactil? in the full CMI. 3. WHAT IF I AM TAKING OTHER MEDICINES? Some medicines may interfere with Largactil and affect how it works. A list of these medicines is in Section 3. What if I am taking other medicines? in the full CMI. 4. HOW DO I USE LARGACTIL? • Your doctor or pharmacist will tell you how many tablets or how much syrup you will need to take each day. This depends on your condition and whether or not you are taking any other medicines. More instructions can be found in Section 4. How do I use Largactil? in the full CMI. 5. WHAT SHOULD I KNOW WHILE USING LARGACTIL? THINGS YOU SHOULD DO • Remind any doctor, dentist or pharmacist you visit that you are using Largactil. • If you become pregnant while taking Largactil, tell your doctor or pharmacist. • You should avoid very cold or very hot environments. • You should avoid exposure to strong sunlight while you are taking Largactil. • Call your doctor straight away if you notice 阅读完整的文件
largactil-ccdsv5-piv14-12may22 1 AUSTRALIAN PRODUCT INFORMATION – LARGACTIL (CHLORPROMAZINE HYDROCHLORIDE) 1 NAME OF THE MEDICINE Chlorpromazine hydrochloride 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Tablets: Each tablet contains 10 mg, 25 mg or 100 mg of chlorpromazine hydrochloride Syrup: Each 1 mL of syrup contains 5 mg of chlorpromazine hydrochloride Injection: The injection solution contains 50 mg/2 mL of chlorpromazine hydrochloride Excipients with known effect: Tablets: Lactose Monohydrate Syrup: Sucrose, sodium sulfite, sodium metabisulfite, sodium benzoate Injection: Sodium sulfite, sodium metabisulfite For the full list of excipients, see Section 6.1 List of Excipients. 3 PHARMACEUTICAL FORM Tablets, Syrup, Injection Solution TABLETS 10 mg: white to off-white, circular biconvex, film-coated tablets one face impressed LG10 with the reverse side plain film coated tablet 25 mg: white to off-white, circular biconvex, film-coated tablets one face impressed LG25 with the reverse side plain film coated 100 mg: white to off-white, circular biconvex, film-coated tablets one face impressed LG100 with the reverse side plain film coated SYRUP The syrup is a clear bright, golden brown, syrupy liquid INJECTION The injection solution is a clear, bright, very pale yellow liquid. largactil-ccdsv5-piv14-12may22 2 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of acute functional psychosis (e.g. schizophrenia, mania or psychotic depression). Long-term treatment of schizophrenia. Short-term treatment of agitation and severe depression. Severe behavioural disturbances, as can be found in some children with mental retardation or autism, including the treatment of self-injurious and aggressive behaviour or overactivity. Use of chlorpromazine should be in conjunction with an appropriate non-pharmacological management program and long-term use should only be carried out under the supervision of a physician experienced in the management of psychotic disorders in children. In the management of terminal illness t 阅读完整的文件